Background
Necrotic enteritis is a widespread disease in poultry caused by
Clostridium perfringens.
We previously reported that dietary arginine supplementation protected the intestinal mucosa of broiler chickens with necrotic enteritis, but the related protective mechanisms remain unclear. The
in vivo
trial was designed as a 2 × 2 factorial arrangement to evaluated the effects of arginine supplementation on inflammatory responses, arginine transporters, arginine catabolism and JAK-STAT signalling pathway in broiler chickens challenged with
C. perfringens
or without
C. perfringens
. Furthermore, we validated the
in vivo
results using intestinal epithelial cells of chicken embryos.
Results
C. perfringens
infection markedly increased gut gross pathological and histopathological lesion scores, promoted liver
C. perfringens
invasion, reduced serum arginine levels, and elevated jejunal mucosal lysozyme activities (
P
< 0.05), but these effects were significantly reversed by arginine supplementation
in vivo
(
P
< 0.05). The challenge significantly increased serum procalcitonin levels, jejunal mucosal iNOS activities and jejunal
IL-6
,
TGF-β3
, cationic amino acid transporter (
CAT
)
-1
, and
CAT-3
mRNA expression (
P
< 0.05), whereas arginine supplementation significantly reduced jejunal
IFN-γ
,
IL-1β
,
IL-6
,
IL-10
,
TGF-β3
, and
CAT-3
mRNA expression (
P
< 0.05). Arginine supplementation significantly attenuated the
C. perfringens
challenge-induced increases in jejunal
iNOS
, arginase 2, arginine decarboxylase, arginine:glycine amidinotransferase,
JAK1
,
JAK3
,
STAT1
, and
STAT6
mRNA expression (
P
< 0.05). The
in vitro
experiment showed that
C. perfringens
challenge markedly increased cellular cytotoxicity and the mRNA expression of
IL-1β
,
IL-8
,
IL-10
,
CAT-1
and
CAT-3
(
P
< 0.05), which were significantly reversed by 50 μmol/L and/or 400 μmol/L arginine pre-treatment (
P
< 0.05).
Conclusions
Arginine prevented
...